CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 687283-687510 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"It appears that when Omalizumab is added to the combination H1receptor antagonist, Cetirizine, and nasal corticosteroid, Mometasone furoate, the primary end points (rhinomanometry and symptom scores) are significantly improved.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T20262","span":{"begin":0,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T20262","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1137","span":{"begin":0,"end":227},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1137","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T88","span":{"begin":0,"end":227},"obj":"Sentence"}],"attributes":[{"subj":"T88","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93c6","default":true},{"id":"Epistemic_Statements","color":"#93e0ec"},{"id":"CORD-19_Custom_license_subset","color":"#ecde93"}]}]}}